L-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy. (2019)
Attributed to:
Dissecting the impact of L-selectin on T lymphocyte dependent tumour immunity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2019.01321
PubMed Identifier: 31249570
Publication URI: http://europepmc.org/abstract/MED/31249570
Type: Journal Article/Review
Volume: 10
Parent Publication: Frontiers in immunology
ISSN: 1664-3224